Search results
A New Human Blood Group - Nature
Nature· 1 day agoDURING the investigation of a hæmolytic transfusion reaction, it was observed that the patient's serum contained an isoantibody the reactions of which did not correspond with those of known ...
Redefining cancer therapy with photoimmunotherapy
Nature· 1 day agoClinical trials are under way for a new antibody-based anticancer platform called photoimmunotherapy (PIT), which has shown promise in selectively...
Effect of Antibodies against Rat γ-Globulin or Rat Albumin on Isolated Peritoneal Rat Mast Cells -...
Nature· 1 day agoIT HAS recently been shown1 that rabbit anti-rat serum causes typical anaphylaxis in albino rats on intravenous injection; on isolated peritoneal mast cells this anti-serum induces characteristic ...
An Attempt to produce Hæmolytic Disease in Lambs - Nature
Nature· 1 day agoAs a result, 4 of the ewes produced immune antibodies which reacted with the red cells of their mates; but their lambs did not develop hæmolytic disease even though at least 2 of them ingested ...
Revitope—third-generation T cell engager immunotherapies
Nature· 1 day agoRevitope Oncology, Inc. is a privately owned company in Cambridge, MA, that focuses on the development of next-generation T cell engager immunotherapies for a variety of solid cancer indications ...
Next-generation animal health vaccines
Nature· 1 day agoThere are many successful examples of treatments that were used in animal health care before being used in humans. Indeed, not soon after the approval of...
Reply to “PDLIM5 is not a neuronal CaV2.2 adaptor protein” - Nature Neuroscience
Nature· 1 day agoThe Abnova antibody used by Stanley and colleagues was raised against the entire ENH protein (a total of 597 amino acids) and this may explain some of the differences between ...
Jean Dausset 1916–2009 - Nature Immunology
Nature· 1 day agoJean Dausset was born on 19 October 1916 in Toulouse, France. In 1949, after a sabbatical year at Harvard Medical School, he returned to the Transfusion Center of Saint Antoine Hospital (Paris ...
Human Precipitins against Common Pathogenic and Non-Pathogenic Fungi - Nature
Nature· 1 day agoTHE demonstration in human sera of precipitating antibodies against common pathogenic and non-pathogenic fungi is of interest for the study of fungal antigens and for the study in man of reactions ...
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA
PharmiWeb· 5 days agoKVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remodel the tumor microenvironment (TME) to overcome acquired ...
